Parenteral hydralazine revisited

The Journal of Emergency Medicine
D R PowersJ D Wallin

Abstract

Historical aspects of the development and application of the vasodilator hydralazine are reviewed. The pharmacology, pharmacokinetics, metabolism, and mechanism of action are discussed, with emphasis on the parenteral use of this drug. It is reiterated that parenteral hydralazine is the preferred drug for the treatment of severe preeclampsia, but its usefulness in other forms of accelerated hypertension is also addressed. Through comparisons with other established antihypertensive agents, the efficacy and pharmacoeconomic potential of hydralazine are stressed.

References

Aug 5, 1976·The New England Journal of Medicine·J Koch-Weser
Feb 2, 1989·The American Journal of Cardiology·D I Barry
Oct 22, 1987·The New England Journal of Medicine·R W DeSanctisM J Buckley
May 1, 1986·Southern Medical Journal·J A SpinnatoG D Anderson
Sep 12, 1985·The New England Journal of Medicine·M D Lindheimer, A I Katz
Jul 1, 1985·Cardiovascular Research·A B Ebeigbe, C P Aloamaka
Mar 23, 1972·The New England Journal of Medicine·R ZacestJ Koch-Weser
Jan 24, 1974·The New England Journal of Medicine·J Koch-Weser
Jun 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·D Moore-Jones, H M Perry
Sep 15, 1984·Biochemical Pharmacology·M Jacobs
Sep 1, 1984·Obstetrics and Gynecology·B M SibaiG D Anderson
Jan 1, 1983·Gynecologic and Obstetric Investigation·N O LunellS Thornström
Apr 1, 1984·American Journal of Obstetrics and Gynecology·J A PritchardS A Pritchard
May 1, 1982·Clinical Pharmacokinetics·T M LuddenM S Lin
May 1, 1994·British Journal of Obstetrics and Gynaecology·S Paterson-BrownM de Swiet
Aug 1, 1995·Journal of Clinical Pharmacology·W AbdelwahabA Landau
Jan 1, 1996·British Journal of Obstetrics and Gynaecology·P López-JaramilloE Nava
Feb 1, 1955·The American Journal of the Medical Sciences·W M HUGHESJ H MOYER
Oct 1, 1950·Proceedings of the Society for Experimental Biology and Medicine·E D FREIS, F A FINNERTY
Dec 1, 1951·Journal of the American Medical Association·I H PAGE
Jan 1, 1950·Proceedings of the Society for Experimental Biology and Medicine·F C REUBI
Sep 11, 2013·Circulation·Aaron S KellyUNKNOWN American Heart Association Atherosclerosis, Hypertension, and Obesity in the Young Committee of the Council on Cardiovascula

❮ Previous
Next ❯

Citations

Aug 24, 2004·International Journal of Obstetric Anesthesia·H Brodie, A M Malinow
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunBalakrishna Kalluraya
Jan 1, 2009·Acta Crystallographica. Section E, Structure Reports Online·Hoong-Kun FunSuchada Chantrapromma
Mar 2, 2006·Journal of Translational Medicine·Claudia ArceAlfonso Dueñnas-Gonzalez
Jun 29, 2013·Annals of Intensive Care·Diamantino Ribeiro SalgadoJean-Louis Vincent
May 26, 2009·Journal of Clinical Anesthesia·Paul E Marik, Joseph Varon
Jul 29, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·Denise Rhoney, W Frank Peacock
Apr 7, 2012·International Anesthesiology Clinics·Manuel L Fontes, Joseph Varon
Feb 11, 2000·The Annals of Pharmacotherapy·B L Erstad, J F Barletta
Jun 3, 2015·Journal of Cardiovascular Pharmacology and Therapeutics·Meghan N McCombTien M H Ng
Jul 14, 2001·Critical Care Clinics·W J Elliott

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.